enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - ošípané - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.
monitor fetálny sonicaidteam
huntleigh healthcare ltd., diagnostic products division 35 portmanmoor road cf 24 5 hn cardiff spojené kráľovstvo veľkej británie a severného Írska -
dúhovka umelá silikónová antificial iris
schmidt intraocularlinsen gmbh. wasterwaldstrasse 11-13 53757 augistin nemecko -
salmoporc, lyofilizát a rozpúšťadlo na injekčnú suspenziu pre ošípané
ceva animal health slovakia, slovenská republika - inj.
vzduch medicinálny syntetický siad
siad slovakia spol. s r.o., slovensko - medicinálny vzduch - 87 - varia i
náplasť hemostatická hematrix
hematris wound care gmbh prof.-messerchmidt-strasse 3 855 79 neubiberg nemecko -
náplasť hemostatická hematrix
hematris wound care gmbh prof.-messerchmidt-strasse 3 855 79 neubiberg nemecko -
cevac salmovac
ceva animal health slovakia, slovenská republika - lyof.
peditrace
fresenius kabi s.r.o., Česká republika - elektrolyty v kombinácii s inými liečivami - 39 - soli a ionty pro p.o. a parent. aplikÁciu
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - iné alimentárny trakt a metabolizmus výrobky, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.